体外診断薬の品質管理市場：製品、販売業者、用途、エンドユーザー別-2023-2030年の世界予測

体外診断薬の品質管理の世界市場は、2023年にCAGR 8.30%で13億7,654万米ドルが予測され、2030年には24億1,276万米ドルに達するという驚異的な成長を遂げると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界の体外診断薬の品質管理市場を評価するために不可欠です。事業戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.体外診断薬の品質管理の世界市場規模および予測は？

2.予測期間中、世界の体外診断薬の品質管理市場を形成するCOVID-19の阻害要因と影響は？

3.体外診断薬の品質管理の世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は？

4.体外診断薬の品質管理の世界市場における競争戦略は？

5.体外診断薬の品質管理の世界市場における技術動向と規制の枠組みは？

6.体外診断薬の品質管理の世界市場における主要ベンダーの市場シェアは？

7.体外診断薬の品質管理の世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 慢性疾患および感染症の蔓延と体外診断の必要性
    • ポイントオブケア診断技術とサードパーティの品質管理に対する需要の増大
    • 診断装置とサービスの安全性を確保するための政府規制
  • 抑制要因
    • 高額なIVD品質管理サービス
  • 機会
    • 体外診断用スマート品質管理導入に向けた研究開発活動
    • シリコン技術と多検体制御における技術進歩
  • 課題
    • IVD検査製品の承認と不正確さの問題に関する厳しい規制
• 市場動向
• COVID-19の累積的な影響
• ロシア・ウクライナ紛争の累積的影響
• 高インフレの累積的影響
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 規制の枠組み
• 顧客のカスタマイズ

第6章 体外診断薬の品質管理市場：提供別

• データ管理ソリューション
• 品質保証サービス
• 品質管理製品
  • 血清/血漿ベースのコントロール
  • 尿ベースのコントロール
  • 全血ベースのコントロール

第7章 体外診断薬の品質管理市場販売代理店別

• OEM
• サードパーティ制御メーカー
  • 独立したメーカーの管理
  • 機器固有のコントロール

第8章 体外診断薬の品質管理市場：用途別

• 臨床化学
• 凝固または止血
• 血液学
• 免疫化学
• 微生物学
• 分子診断学

第9章 体外診断薬の品質管理市場：エンドユーザー別

• 臨床検査室
• 病院
• 調査および学術機関

第10章 南北アメリカの体外診断薬の品質管理市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の体外診断薬の品質管理市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの体外診断薬の品質管理市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• FPNVポジショニングマトリクス
• 市場シェア分析：主要企業別
• 競合シナリオ分析：主要企業別
  • 合併・買収
  • 契約、コラボレーション、パートナーシップ
  • 新製品発売と機能強化
  • 投資、資金調達
  • 受賞・表彰・拡大

第14章 掲載企業一覧

第15章 付録

• ディスカッションガイド
• ライセンスと価格について

LIST OF FIGURES

• FIGURE 1. IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET RESEARCH PROCESS
• FIGURE 2. IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2022 VS 2030
• FIGURE 3. IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2022 VS 2030 (%)
• FIGURE 5. IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2022 VS 2030 (%)
• FIGURE 6. IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
• FIGURE 7. IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
• FIGURE 8. IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 9. IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET DYNAMICS
• FIGURE 10. IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 15. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 18. IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 19. IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 5. IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DATA MANAGEMENT SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY ASSURANCE SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 8. IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY SERUM/PLASMA-BASED CONTROLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY URINE-BASED CONTROLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY WHOLE-BLOOD-BASED CONTROLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 13. IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OEM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 15. IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY INDEPENDENT MANUFACTURER CONTROLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY INSTRUMENT-SPECIFIC CONTROLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 19. IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CLINICAL CHEMISTRY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY COAGULATION OR HEMOSTASIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY IMMUNOCHEMISTRY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY MICROBIOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 26. IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 38. ARGENTINA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 39. ARGENTINA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 40. ARGENTINA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 41. ARGENTINA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 42. BRAZIL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 43. BRAZIL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 44. BRAZIL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 45. BRAZIL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 46. BRAZIL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 47. BRAZIL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 48. CANADA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 49. CANADA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 50. CANADA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 51. CANADA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 52. CANADA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 53. CANADA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 54. MEXICO IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 55. MEXICO IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 56. MEXICO IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 57. MEXICO IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 58. MEXICO IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 59. MEXICO IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 60. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 61. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 62. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 63. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 64. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 65. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 67. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 68. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 69. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 70. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 71. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 72. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 73. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 74. AUSTRALIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 75. AUSTRALIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 76. AUSTRALIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 77. AUSTRALIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 78. AUSTRALIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 79. AUSTRALIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 80. CHINA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 81. CHINA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 82. CHINA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 83. CHINA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 84. CHINA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 85. CHINA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 86. INDIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 87. INDIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 88. INDIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 89. INDIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 90. INDIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. INDIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 92. INDONESIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 93. INDONESIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 94. INDONESIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 95. INDONESIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 96. INDONESIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 97. INDONESIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 98. JAPAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 99. JAPAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 100. JAPAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 101. JAPAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 102. JAPAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 103. JAPAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 104. MALAYSIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 105. MALAYSIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 106. MALAYSIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 107. MALAYSIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 108. MALAYSIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 109. MALAYSIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 110. PHILIPPINES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 111. PHILIPPINES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 112. PHILIPPINES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 113. PHILIPPINES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 114. PHILIPPINES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 115. PHILIPPINES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 116. SINGAPORE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 117. SINGAPORE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 118. SINGAPORE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 119. SINGAPORE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 120. SINGAPORE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 121. SINGAPORE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 122. SOUTH KOREA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 123. SOUTH KOREA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH KOREA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH KOREA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH KOREA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH KOREA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 128. TAIWAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 129. TAIWAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 130. TAIWAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 131. TAIWAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 132. TAIWAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 133. TAIWAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 134. THAILAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 135. THAILAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 136. THAILAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 137. THAILAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 138. THAILAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 139. THAILAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 140. VIETNAM IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 141. VIETNAM IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 142. VIETNAM IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 143. VIETNAM IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 144. VIETNAM IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 145. VIETNAM IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 146. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 147. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 148. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 149. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 150. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 151. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 152. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 153. DENMARK IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 154. DENMARK IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 155. DENMARK IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 156. DENMARK IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 157. DENMARK IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 158. DENMARK IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 159. EGYPT IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 160. EGYPT IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 161. EGYPT IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 162. EGYPT IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 163. EGYPT IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 164. EGYPT IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 165. FINLAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 166. FINLAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 167. FINLAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 168. FINLAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 169. FINLAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 170. FINLAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 171. FRANCE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 172. FRANCE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 173. FRANCE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 174. FRANCE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 175. FRANCE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 176. FRANCE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 177. GERMANY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 178. GERMANY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 179. GERMANY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 180. GERMANY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 181. GERMANY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 182. GERMANY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 183. ISRAEL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 184. ISRAEL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 185. ISRAEL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 186. ISRAEL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 187. ISRAEL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 188. ISRAEL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 189. ITALY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 190. ITALY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 191. ITALY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 192. ITALY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 193. ITALY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 194. ITALY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 195. NETHERLANDS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 196. NETHERLANDS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 197. NETHERLANDS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 198. NETHERLANDS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 199. NETHERLANDS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 200. NETHERLANDS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 201. NIGERIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 202. NIGERIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 203. NIGERIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 204. NIGERIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 205. NIGERIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 206. NIGERIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 207. NORWAY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 208. NORWAY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 209. NORWAY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 210. NORWAY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 211. NORWAY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 212. NORWAY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 213. POLAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 214. POLAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 215. POLAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 216. POLAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 217. POLAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 218. POLAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 219. QATAR IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 220. QATAR IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 221. QATAR IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 222. QATAR IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 223. QATAR IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 224. QATAR IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 225. RUSSIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 226. RUSSIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 227. RUSSIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 228. RUSSIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 229. RUSSIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 230. RUSSIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 231. SAUDI ARABIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 232. SAUDI ARABIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 233. SAUDI ARABIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 234. SAUDI ARABIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 235. SAUDI ARABIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 236. SAUDI ARABIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 237. SOUTH AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 238. SOUTH AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 239. SOUTH AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 240. SOUTH AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 241. SOUTH AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 242. SOUTH AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 243. SPAIN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 244. SPAIN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 245. SPAIN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 246. SPAIN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 247. SPAIN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 248. SPAIN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 249. SWEDEN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 250. SWEDEN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 251. SWEDEN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 252. SWEDEN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 253. SWEDEN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 254. SWEDEN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 255. SWITZERLAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 256. SWITZERLAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 257. SWITZERLAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 258. SWITZERLAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 259. SWITZERLAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 260. SWITZERLAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 261. TURKEY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 262. TURKEY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 263. TURKEY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 264. TURKEY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 265. TURKEY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 266. TURKEY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 267. UNITED ARAB EMIRATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 268. UNITED ARAB EMIRATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 269. UNITED ARAB EMIRATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 270. UNITED ARAB EMIRATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 271. UNITED ARAB EMIRATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 272. UNITED ARAB EMIRATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 273. UNITED KINGDOM IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 274. UNITED KINGDOM IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 275. UNITED KINGDOM IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 276. UNITED KINGDOM IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 277. UNITED KINGDOM IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 278. UNITED KINGDOM IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 279. IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 280. IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 281. IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET LICENSE & PRICING

The Global In-Vitro Diagnostics Quality Control Market is forecasted to grow significantly, with a projected USD 1,376.54 million in 2023 at a CAGR of 8.30% and expected to reach a staggering USD 2,412.76 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global In-Vitro Diagnostics Quality Control Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global In-Vitro Diagnostics Quality Control Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Offering, market is studied across Data Management Solutions, Quality Assurance Services, and Quality Control Products. The Quality Control Products is further studied across Serum/Plasma-Based Controls, Urine-Based Controls, and Whole-Blood-Based Controls. The Quality Control Products commanded largest market share of 41.46% in 2022, followed by Data Management Solutions.

Based on Distributor, market is studied across OEM and Third-Party Control Manufacturers. The Third-Party Control Manufacturers is further studied across Independent Manufacturer Controls and Instrument-Specific Controls. The Third-Party Control Manufacturers commanded largest market share of 64.76% in 2022, followed by OEM.

Based on Application, market is studied across Clinical Chemistry, Coagulation or Hemostasis, Hematology, Immunochemistry, Microbiology, and Molecular Diagnostics. The Immunochemistry commanded largest market share of 21.32% in 2022, followed by Clinical Chemistry.

Based on End-User, market is studied across Clinical Laboratories, Hospitals, and Research & Academic Institutes. The Clinical Laboratories commanded largest market share of 57.27% in 2022, followed by Hospitals.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded largest market share of 37.36% in 2022, followed by Americas.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global In-Vitro Diagnostics Quality Control Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global In-Vitro Diagnostics Quality Control Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global In-Vitro Diagnostics Quality Control Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global In-Vitro Diagnostics Quality Control Market?

4. What is the competitive strategic window for opportunities in the Global In-Vitro Diagnostics Quality Control Market?

5. What are the technology trends and regulatory frameworks in the Global In-Vitro Diagnostics Quality Control Market?

6. What is the market share of the leading vendors in the Global In-Vitro Diagnostics Quality Control Market?

7. What modes and strategic moves are considered suitable for entering the Global In-Vitro Diagnostics Quality Control Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. In-Vitro Diagnostics Quality Control Market, by Offering, 2022 vs 2030
• 4.3. In-Vitro Diagnostics Quality Control Market, by Distributor, 2022 vs 2030
• 4.4. In-Vitro Diagnostics Quality Control Market, by Application, 2022 vs 2030
• 4.5. In-Vitro Diagnostics Quality Control Market, by End-User, 2022 vs 2030
• 4.6. In-Vitro Diagnostics Quality Control Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Prevalence of chronic and infectious diseases and need for in-vitro diagnostics
    • 5.1.1.2. Growing demand for point-of-care diagnostic technologies and third-party quality controls
    • 5.1.1.3. Government regulations to ensure the safety of diagnostics devices and services
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of IVD quality control services
  • 5.1.3. Opportunities
    • 5.1.3.1. R&D activities to introduce smart quality control for in-vitro diagnostics
    • 5.1.3.2. Technological advancement in silicon technology and multianalyte controls
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent regulations for approval of IVD test products and inaccuracy issues
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. In-Vitro Diagnostics Quality Control Market, by Offering

• 6.1. Introduction
• 6.2. Data Management Solutions
• 6.3. Quality Assurance Services
• 6.4. Quality Control Products
  • 6.4.1. Serum/Plasma-Based Controls
  • 6.4.2. Urine-Based Controls
  • 6.4.3. Whole-Blood-Based Controls

7. In-Vitro Diagnostics Quality Control Market, by Distributor

• 7.1. Introduction
• 7.2. OEM
• 7.3. Third-Party Control Manufacturers
  • 7.3.1. Independent Manufacturer Controls
  • 7.3.2. Instrument-Specific Controls

8. In-Vitro Diagnostics Quality Control Market, by Application

• 8.1. Introduction
• 8.2. Clinical Chemistry
• 8.3. Coagulation or Hemostasis
• 8.4. Hematology
• 8.5. Immunochemistry
• 8.6. Microbiology
• 8.7. Molecular Diagnostics

9. In-Vitro Diagnostics Quality Control Market, by End-User

• 9.1. Introduction
• 9.2. Clinical Laboratories
• 9.3. Hospitals
• 9.4. Research & Academic Institutes

10. Americas In-Vitro Diagnostics Quality Control Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific In-Vitro Diagnostics Quality Control Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa In-Vitro Diagnostics Quality Control Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. FPNV Positioning Matrix
• 13.2. Market Share Analysis, By Key Player
• 13.3. Competitive Scenario Analysis, By Key Player
  • 13.3.1. Merger & Acquisition
    • 13.3.1.1. Werfen Completes Acquisition of Immucor
    • 13.3.1.2. EDX Completes Acquisition of IVD Products Developer Torax Biosciences
    • 13.3.1.3. Veranex Acquires Devicia and Clarvin, Expanding Regulatory, Quality, and Clinical Expertise for IVD and Medical Devices
  • 13.3.2. Agreement, Collaboration, & Partnership
    • 13.3.2.1. Siemens Healthineers and Unilabs Launch Strategic Partnership For Latest Diagnostic Testing Infrastructure To Improve Patients' Care
  • 13.3.3. New Product Launch & Enhancement
    • 13.3.3.1. Qiagen Unveils IVD Platform For Automated Sampling In Laboratories
  • 13.3.4. Investment & Funding
    • 13.3.4.1. InDevR Raises $9 Million in Series B Financing and Partners with bioMerieux
  • 13.3.5. Award, Recognition, & Expansion
    • 13.3.5.1. Indian Subsidiary Acquires ISO13485 Certification
    • 13.3.5.2. UL Solutions Expands Scope For In Vitro Diagnostics

14. List of Company Mentioned

15. Appendix

• 15.1. Discussion Guide
• 15.2. License & Pricing